Like CTLA-4 and PD-1, certain miRs, such as miR-146a, promote down-regulation of both innate and adaptive immune responses and may impact ICI-related survival [173], in part by counteracting cell escape mechanisms in the tumor microenvironment [174]. The gene discussed is PDCD1; the disease is neoplasm.